FDA Investigator James C Henry
James C Henry has conducted inspections on 50 sites in 2 countries as of 19 Oct 2009. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
50
Last Inspection Date:
19 Oct 2009
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
South Africa
FDA Investigators that have inspected at least one site in common with James C Henry:
Alex G Kalugin,
Alexander M Kay,
Anita Narula, PhD,
Astrida B Mattson,
Bryce E Mansfield,
Carl A Anderson,
Celia L Hutchinstein,
Christina L Norton,
Christopher J Lee,
Connie P Rezendes,
David J Gomes,
Dawn E Barkans,
Deborah A Nebenzahl,
Dennis G Kawabata,
Dennis R Hudson,
Dolores E Price,
Elizabeth S Howell,
Elva M Ibarra,
Erika V Butler,
Estefania Fernandez,
Gerard Pde Leon,
Gloria J Baca, MS,
Heika R Tait,
Hugh A Grimoldby,
Ingrid A Zambrana,
Irvine Irvine,
Jane M Kreis,
Jeffrey J Leclair,
Joanne M Fukuda,
Joel D Martinez,
John E Emmert,
Julian C Hanson,
Julie A Stocklin,
Kathryn A Krentz,
Ligia M Sanders,
Lisa A Bowden,
Lisa K Capron,
Maria Pkelly Doggett, MBA,
Marijo B Kambere, PhD,
Mark W Babbitt,
Michael S Hudson,
Mihaly S Ligmond,
Nancy E Byerly,
Nataniel Phillips Sylvain, PhD,
S Lori Brown, PhD MPH,
Sangeeta M Khurana, PhD,
Sherri N Rohlf, MD,
Stephanie A Jameson,
Stephen R Souza,
Steven M Galvez,
Tracy K Li,
William C Hughes
James C Henry's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2001 | EIR | Dr. Trevor Winter - EIR, 2001-04-26 |
December, 2000 | EIR | Northwest Women's Clinic - EIR, 2000-12-05 |
March, 2000 | EIR | John Rabkin, M.D. - EIR, 2000-03-31 |
June, 2002 | EIR | Noonan, Michael J Md - EIR, 2002-06-21 |
January, 2000 | EIR | Hanifin, Jon M MD - EIR, 2000-01-21 |
December, 2000 | FDA 483 | Northwest Women's Clinic - Form 483, 2000-12-05 |
April, 2001 | FDA 483 | Phillipson, Beverley E., M.D. - Form 483, 2001-04-06 |
September, 2000 | FDA 483 | Rich Distributing - Form 483, 2000-09-29 |
December, 2000 | FDA 483 | Amram Inc. - Form 483, 2000-12-18 |
May, 2000 | EIR | Frison, Linda D., M.D. - EIR, 2000-05-03 |
April, 2001 | EIR | Dr. Trevor Winter - EIR, 2001-04-27 |
July, 2001 | EIR | Steven Teeny, M.D. - EIR, 2001-07-11 |
April, 2001 | EIR | Phillipson, Beverley E., M.D. - EIR, 2001-04-06 |
March, 2002 | EIR | Silgan Unicep Packaging, LLC. - EIR, 2002-03-05 |
December, 2001 | EIR | Mc Clung Michael R Md - EIR, 2001-12-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more